MECLAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Meclan, and what generic alternatives are available?
Meclan is a drug marketed by Johnson And Johnson and is included in one NDA.
The generic ingredient in MECLAN is meclocycline sulfosalicylate. There are twelve drug master file entries for this compound. Additional details are available on the meclocycline sulfosalicylate profile page.
Summary for MECLAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Patent Applications: | 509 |
DailyMed Link: | MECLAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MECLAN
US Patents and Regulatory Information for MECLAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Johnson And Johnson | MECLAN | meclocycline sulfosalicylate | CREAM;TOPICAL | 050518-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |